Aarey Drugs & Pharmaceuticals Limited Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Aarey Drugs & Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.20 Million ≈ $88.66K USD) by net assets (Rs1.19 Billion ≈ $12.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Aarey Drugs & Pharmaceuticals Limited (2009–2025)

Cash flow conversion efficiency of Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. This chart illustrates how Aarey Drugs & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Aarey Drugs & Pharmaceuticals Limited stock price for real-time trading data and today's change.

Aarey Drugs & Pharmaceuticals Limited Cash Flow Conversion Ratio Explained

Aarey Drugs & Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Aarey Drugs & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarey Drugs & Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see market value of Aarey Drugs & Pharmaceuticals Limited for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Kestrel Group, Ltd. NASDAQ:KG	-0.227x
Wellbiotec Co. Ltd. KO:010600	-0.033x
Yuanta Securities Korea Co Ltd Preference Shares KO:003475	0.161x
SHL Telemedicine Ltd American Depositary Shares NASDAQ:SHLT	-0.004x
Pre-Built Public Company Limited BK:PREB	0.106x
Tycoons Worldwide Group (Thailand) Public Company Limited BK:TYCN	-0.050x
Omni-Lite Industries Canada Inc. V:OML	0.030x
Templeton Emerging Markets Investment Trust TEMIT LSE:TEM	0.003x

Annual Cash Flow Conversion Efficiency for Aarey Drugs & Pharmaceuticals Limited (2009–2025)

The table below shows the annual cash flow conversion efficiency of Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. Review AAREYDRUGS cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.38 Billion ≈ $14.98 Million	Rs8.95 Million ≈ $96.77K	0.006x	+128.66%
2024-03-31	Rs1.33 Billion ≈ $14.36 Million	Rs-29.94 Million ≈ $-323.77K	-0.023x	-106.66%
2023-03-31	Rs1.17 Billion ≈ $12.70 Million	Rs-12.81 Million ≈ $-138.55K	-0.011x	+72.40%
2022-03-31	Rs1.14 Billion ≈ $12.29 Million	Rs-44.93 Million ≈ $-485.90K	-0.040x	-171.37%
2021-03-31	Rs988.60 Million ≈ $10.69 Million	Rs54.77 Million ≈ $592.32K	0.055x	+79.06%
2020-03-31	Rs923.46 Million ≈ $9.99 Million	Rs28.57 Million ≈ $309.00K	0.031x	+288.83%
2019-03-31	Rs865.53 Million ≈ $9.36 Million	Rs6.89 Million ≈ $74.48K	0.008x	+103.14%
2018-03-31	Rs802.45 Million ≈ $8.68 Million	Rs-203.51 Million ≈ $-2.20 Million	-0.254x	-1427.42%
2017-03-31	Rs503.60 Million ≈ $5.45 Million	Rs9.62 Million ≈ $104.05K	0.019x	-87.61%
2016-03-31	Rs366.97 Million ≈ $3.97 Million	Rs56.59 Million ≈ $612.01K	0.154x	+67.84%
2015-03-31	Rs354.09 Million ≈ $3.83 Million	Rs32.53 Million ≈ $351.84K	0.092x	+851.96%
2014-03-31	Rs345.21 Million ≈ $3.73 Million	Rs-4.22 Million ≈ $-45.62K	-0.012x	-112.13%
2013-03-31	Rs334.70 Million ≈ $3.62 Million	Rs33.72 Million ≈ $364.71K	0.101x	+136.83%
2012-03-31	Rs328.12 Million ≈ $3.55 Million	Rs-89.76 Million ≈ $-970.74K	-0.274x	+39.84%
2011-03-31	Rs219.05 Million ≈ $2.37 Million	Rs-99.61 Million ≈ $-1.08 Million	-0.455x	-254.49%
2010-03-31	Rs92.08 Million ≈ $995.81K	Rs-11.81 Million ≈ $-127.73K	-0.128x	-3666.00%
2009-03-31	Rs83.97 Million ≈ $908.15K	Rs302.06K ≈ $3.27K	0.004x	--

About Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$33.51 Million

Rs3.10 Billion INR

Market Cap Rank

#23185 Global

#1281 in India

Share Price

Rs109.29

Change (1 day)

+3.34%

52-Week Range

Rs50.75 - Rs113.87

All Time High

Rs113.87